Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: art slott who wrote (2652)	8/12/1998 9:56:00 PM
From: KAKALAK	Read Replies (1) \| Respond to of 3725

I was told what I was told. I have no established integrity. I'm just another faceless putz who coughed up the fee to post on S.I. AGAIN, 7 units SOLD within Q2 15-20 will be SOLD in addition to the above 7 (not just booked) in Q3 & Q4. Also, there will be language in Q2 report which states that Q2 would have been profitable had Heartscan not been on the books as a loss. Report will forecast that Q3 and Q4 will be in the black with the above sales (actually, I heard up to 25 units) and Heartscan out of the picture. You'll see if I am correct as Q2 will be out soon. Determine for yourselves if this info (if correct) will move the share price. Please post your thoughts. I AM KAKALAK